Adiponectin and visfatin as potential biomarkers of cardiovascular disease in postmenopausal women

A Cybulska,D Schneider-Matyka,D Cwiek,E Grochans,K Rachubinska
DOI: https://doi.org/10.1093/eurjcn/zvae098.057
2024-07-01
European Journal of Cardiovascular Nursing
Abstract:Abstract Background Adiponectin and visfatin are involved in many changes associated with obesity and metabolic disorders so may be related to metabolic syndrome and cardiovascular disease. During the perimenopausal period, the risk of obesity and cardiometabolic diseases increases. Therefore, the aim of this study was to assess the relationship between cardiometabolic parameters and circulating levels of visfatin and adiponectin in perimenopausal women with regard to their obesity status. Material and methods This survey-based study was conducted among 168 perimenopausal women. It involved the use of questionnaires, anthropometric measurements, blood pressure measurements, and venous blood collection. Results Our study found that visceral adiposity index (VAI) and lipid accumulation product (LAP) were negatively correlated with adiponectin levels. Preliminary multivariate linear regression analysis revealed a positive correlation between circulating visfatin and IL-6 levels. Adiponectin was negatively correlated with HbA1C, fasting blood glucose, insulin, and triglycerides. Furthermore, circulating adiponectin was positively correlated with HDL, and negatively with HOMA-IR. Conclusions In the women studied, some adipokines may have played a significant role in the development of obesity, metabolic syndrome, and cardiometabolic diseases.
nursing,cardiac & cardiovascular systems
What problem does this paper attempt to address?